Á¶¼±Á·±Û·Î¹ú³×Æ®¿öÅ© ½ÃÀÛÆäÀÌÁö·Î °í°´¼¾ÅÍ °øÁö»çÇ× ±¤°í¹®ÀÇ ¸ÞÀϺ¸³»±â
2008³â 12¿ù 29ÀÏ ¿ù¿äÀÏ
¼¼ºì ·ùÁöÇý ½ÅÇØö ´ëÇб³¼ö Ä÷³´Ï½ºÆ®
Àι° °Ë»ö
±è±¤¼ö
À̸§: ±è±¤¼ö
Ãâ»ýÁö: ±æ¸²¼º
Á÷¾÷: ÇмúÀÎ
¾Ù¹ü
´õ¸¹À̺¸±â
ÇзÂ
ÀÔÇг⵵ Á¹¾÷³âµµ Ãâ½ÅÇб³ ¹× Àü°ø
1978.09- 1982.07 ¿¬º¯´ëÇÐÀÇÇпø¾àÇÐÇкÎ
1998.07- 1989.12 ¿¬º¯´ëÇÐÀÇÇпø¾àÇÐÇкΠ¼®»ç
1993.05- 1997.10 Çѱ¹ Ãæ³²´ëÇб³ ¾à´ë ¹Ú»ç
1997.11- 1998.04 Çѱ¹È­Çבּ¸¿ø ¹Ú»çÈÄ
°æ·Â
°æ·Â±â°£ °æ·Â³»¿ª
1982.08-1985.04 ¿¬º¯´ëÇÐÀÇÇпøºÎ¼Óº´¿ø ¾à»ç
1985.05-1993.04 ¿¬º¯ÀÇÇпø ´ëÇоàÇÐÇкΠÁ¶±³. °­»ç
1998.05-ÇöÀç ¿¬º¯´ëÇÐ ¾àÇпø ºÎ±³¼ö,±³¼ö
¼º°ú
¼º°ú³»¿ª
1)2-(1-oxyalky1)-1,4-diox y-9,10-anthraquinone derivti ves:Synthesis and Evaluation of Antitu-
mor Activity. Ar.Pharm.Res,21,198- 206,1998(SCI)
2)Anthracene-1,4,9.10-tetraone derivatives:Syn-thesis and antitumor
activity.Arch.DE.Pharm.1998.331(12),380-384 (SCI).
3)È­·ÎÄ·½¶ÀÇ Á¦Á¶Æ¯Çã.2001.
º» Àι° Á¤º¸´Â web»ó¿¡ °ø°³µÈ ³»¿ëÀ» ¼öÁý, Á¤¸®ÇÑ °ÍÀ¸·Î À߸øµÈ Á¤º¸¸¦ Æ÷ÇÔÇÒ ¼ö ÀÖ½À´Ï´Ù.
À߸øµÈ Á¤º¸ÀÇ ¼öÁ¤À» ¿øÇϽô °æ¿ì, [¸ÞÀÏ ¹®ÀÇÇϱâ]¸¦ ÅëÇØ ¹®ÀÇ Áֽøé, Àι°°Ë»ö ¼öÁ¤¿øÄ¢¿¡ µû¶ó ½Å¼ÓÈ÷ ÆÇ´ÜÇÏ¿© ó¸®Çϵµ·Ï ÇÏ°Ú½À´Ï´Ù.
°í°´¼¾ÅÍ | °øÁö»çÇ× | ±¤°í¹®ÀÇ | ¸ÞÀϺ¸³»±â | ±â»çº¸³»±â | Æ÷·³±Û¸¶´ç¿¡ ±Ûº¸³»±â ¹Ìµð¾î | Æ÷·³ | ÇÃ·Î±× | Áö¿ª³Ý | Á¶¼±Á·»çÀ̹ö¹Ú¹°°ü
Copyright C 2004-2008 ¿¬º¯¿¬¿ìÁ¤º¸±³·ùÇùȸ All Right Reserved.